Mark Hopman

Mark Hopman discloses dealings in Beta Bionics, Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 2 June 2026 to 1 October 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 1 October 2026, the filings show a transaction worth €45k in Beta Bionics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.